Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|July 21, 1990
Quality criteria for early signals of possible adverse drug reactionsI R Edwards, M Lindquist, B E Wiholm, et al.
British Journal of Clinical Pharmacology|May 1, 1987
Captopril: 4 years of post marketing surveillance of all patients in New ZealandI R Edwards, D M Coulter, D M Beasley, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1988
Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven daysB R Dobbs, L R Gazeley, I A Stewart, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patientsL J Schaaf, B R Dobbs, I R Edwards, et al.
European Journal of Clinical Pharmacology|January 1, 1988
The pharmacokinetics of doxifluridine and 5-fluorouracil after single intravenous infusions of doxifluridine to patients with colorectal cancerL J Schaaf, B R Dobbs, I R Edwards, et al.
Drug Safety|January 6, 2001
A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international databaseM Lindquist, M Ståhl, A Bate, et al.
European Journal of Clinical Pharmacology|January 1, 1987
The effect of age on the pharmacokinetics of enoxacinB R Dobbs, L R Gazeley, A J Campbell, et al.
The New Zealand Medical Journal|March 11, 1987
Arrhythmias and Guillain-Barre syndromeR J Dunlop, J N Davidson, M J Orpin, et al.
BMJ (Clinical Research Ed.)|May 19, 2001
Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining studyD M Coulter, A Bate, R H Meyboom, et al.
European Journal of Clinical Pharmacology|October 22, 2002
Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugsA Bate, M Lindquist, R Orre, et al.
Pageof 7